Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02704039 · ClinicalTrials.gov registry record
Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin
A clinical trial, sponsored by University of Texas at Austin.
- Completed
- Registry status
- 239
- Enrollment target
NCT02704039 is a clinical trial that has completed, run by University of Texas at Austin. The registered enrollment target is 239 participants.
The verdict
NCT02704039 has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluorescence spectroscopy) from skin lesion sites. In order to accomplish this objective, the investigators propose to: 1) develop biophysical model for Raman spectroscopy of skin cancers, 2) conduct a clinical pilot study to collect MMS data from a minimum of 250 patients to determine the diagnostic accuracy (sensitivity and specificity) of MMS for diagnosing skin malignancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02704039
The ClinicalTrials.gov registry entry for NCT02704039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02704039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02704039 about?
NCT02704039 is a clinical study titled "Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin". The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluoresc...
What is the current status of trial NCT02704039?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2016-01. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT02704039?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.